検索結果 - Venessa Chin

Two Very Rare Cases of Metastatic Thymic Carcinoma with Sjogren’s Syndrome: A Case Series 著者: Amy E. Smith, Alisa Kane, Francesca Watts, Min Qiu, Venessa Chin

全文の入手

A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma 著者: Udit Nindra, Joshua Hurwitz, Dion Forstner, Venessa Chin, Richard Gallagher, Jia Liu

全文の入手

Impact of COVID-19 on lung cancer care in New South Wales, Australia: real-world data from the EnRICH Program 著者: Bea Brown, Jane Young, Kirsty Galpin, Michael Boyer, Venessa Chin, Chris Brown, Robert Simes

全文の入手

Long‐Term Outcomes and Toxicities in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens 著者: Meghana Maddula, Lauren J. Brown, Venessa Chin, Bo Gao, Ines Pires Da Silva, Adnan Nagrial

全文の入手

Development of clinically meaningful quality indicators for contemporary lung cancer care, and piloting and evaluation in a retrospective cohort; experiences of the Embedding Resea... 著者: Chris Brown, Wendy Cooper, Amy O’Donnell, John Simes, Davinia Seah, Michael Boyer, Jane Young, Karen Briscoe, Ruth Jones, David Barnes, Brian McCaughan, Venessa Chin, Bea Brown, Kirsty Galpin, Diane McPhail

全文の入手

675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC) 著者: Yiran Zhang, Kelly Curtis, Lanjia Lin, John Park, Douglas Adkins, A Dimitrios Colevas, Natalie Rainey, Bruno Fang, Minh Phan, Katie Kerrigan, Venessa Chin, Diogo Alpuim Costa, José Dinis, Siu-Chi Chang Sun, Michael Howland

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma 著者: Jordan F Hastings, Alvaro Gonzalez Rajal, Sharissa L Latham, Jeremy ZR Han, Rachael A McCloy, Yolande EI O'Donnell, Monica Phimmachanh, Alexander D Murphy, Adnan Nagrial, Dariush Daneshvar, Venessa Chin, D Neil Watkins, Andrew Burgess, David R Croucher

全文の入手

ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance 著者: Malinda Itchins, BMedSci, M.B.B.S., FRACP, PhD, Shirley Liang, BSc, Chris Brown, MBiostats, BSc, Tristan Barnes, BSc (Med), M.B.B.S., FRACP, Gavin Marx, BSc, M.B.B.S., FRACP, Venessa Chin, M.B.B.S., FRACP, PhD, Steven Kao, BHB, MBChB, PhD, FRACP, Po Yee Yip, MBChB, FRACP, PhD, Antony J. Mersiades, BMedSc, M.B.B.S., FRACP, MMed (Clin. Epi), Adnan Nagrial, M.B.B.S., FRACP, PhD, Victoria Bray, M.B.B.S., FRACP, PhD, Geoffrey Peters, BPharm, M.B.B.S., FRACP, Sagun Parakh, BSc, MBChB, FRACP, PhD, Kavita Garg, PhD, Bob T. Li, MD, PhD, MPH, Matthew McKay, PhD, Kenneth O'Byrne, M.B.B.S., FRACP, FRCPA, MD, Thomas John, M.B.B.S., FRACP, PhD, Anthony J. Gill, MD, FRCPA, Mark P. Molloy, PhD, Benjamin J. Solomon, M.B.B.S., FRACP, PhD, Nick Pavlakis, BSc, M.B.B.S., MMed (Clin. Epi), PhD, FRACP

全文の入手